Trial intelligence / Profile preview

Femoral nerve block versus local infiltration analgesia for pain control after total knee replacement

ACTRN12614000502639Phase 4Not yet recruiting

Sponsor
Nambour General Hospital
Start
Jun 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine, ketorolac and epinephrine in postoperative pain (3 arms), sponsored by Nambour General Hospital. Primary endpoint: Highest postoperative pain score. Planned start Jun 2014; status: not yet recruiting.

02

Drugs

ropivacaineketorolacepinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12614000502639.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614000502639.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call